Altre lingue Ilsung Is Co., Ltd.

Azioni

A003120

KR7003120003

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 11/06/2024			Variaz. 5gg	Var. 1 gen.
18.500 ^KRW	-0,11%		-2,89%	-21,78%

10/06	SK C&C e Ilsung IS firmano un accordo per la sorveglianza AI dei farmaci	MT
14/05	Ilsung Is Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

SK C&C and Ilsung IS Sign Deal over AI Drug Surveillance	10/06
Ilsung Is Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	11/08/23
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	11/08/23
Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback announced on February 13, 2023, has expired with 598,487 shares, representing 29.77% for KRW 14,994.85 million.	11/08/23
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	15/05/23
Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Ilsung Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 15,000 million worth of its shares.	13/02/23
Ilsung Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.	13/02/23
Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 9, 2022.	10/05/22
Ilsung Pharmaceuticals Co. Ltd.’s Equity Buyback announced on February 9, 2022, has expired with 50,935 shares, representing 3.32% for KRW 4,220.26 million.	09/05/22
Ilsung Pharmaceuticals Co., Ltd. announces an Equity Buyback for 53,200 shares.	09/02/22
Ilsung Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.	09/02/22
Cheil Industries Inc. completed the acquisition of Samsung C&T Corporation from a group of shareholders.	31/08/15
Ilsung Seeks To Sell Stake In Samsung C&T	07/08/15
Samsung C&T : Proxy advisor urges Samsung C&T holders to reject $8 billion merger	02/07/15
Samsung C&T : Cheil, pitching $8 billion merger, pledges higher returns	30/06/15
Ilsung Pharmaceuticals Co. Ltd.(KOSE:A003120) added to Russell Global Index	29/06/15

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ilsung Is Co., Ltd.

Azioni

A003120

KR7003120003

Altre lingue

Filtri